Efficacy of recombinant feline leukemia virus vaccines.
Jarrett
O
O
Department of Veterinary Pathology, University of Glasgow, United Kingdom.
D000818:Animals; D002415:Cats; D004341:Drug Evaluation; D005256:Leukemia Virus, Feline / Q000276:immunology* / Q000302:isolation & purification; D011995:Recombination, Genetic; D012192:Retroviridae Infections / Q000517:prevention & control*; D015682:Retroviridae Proteins, Oncogenic / Q000276:immunology*; D014412:Tumor Virus Infections / Q000517:prevention & control*; D015164:Vaccines, Inactivated / Q000276:immunology; D014759:Viral Envelope Proteins / Q000276:immunology; D014765:Viral Vaccines / Q000276:immunology*
C078788:ALVAC vaccine; D015682:Retroviridae Proteins, Oncogenic; D015164:Vaccines, Inactivated; D014759:Viral Envelope Proteins; D014765:Viral Vaccines; C045569:feline leukemia virus vaccine; C073723:glycoprotein gp70, Feline leukemia virus